Mission
ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER featured in Boston Globe, Mar 2009 |
|
A Boston Globe article written by Lisa Wangsness in March 2009 features ICER in its description of the growing interest in comparative effectiveness research. The article desribes ICER's results on proton beam therapy for low-risk, clinically localized prostate cancer as an example of how comparative effectiveness research could impact healthcare decisions in the future. The entire article is available at the link below: US system to rate health therapies
|